Table 3.
Clinical Characteristics of Patients with COVID-19 Infection and Acro-Ischemia (II)
| Clinical Characteristics | Atypical Raynaud Phenomenon (n=4) | Pseudo-Pernio (n=5) | Severe Microcirculatory Ischemia with Preserve Pulse (n=6) | Dry Gangrene with Arteriosclerosis Obliterans (n=9) |
|---|---|---|---|---|
| Days from disease onset to vascular skin event (mean-range) | 13 (10–14) | 13 (10–14) | 20 (6–24) | 14 (11–18) |
| Skin lesions duration (mean-range) | 15 minutes pulses (7–14) | 10 days (2–14) | 28 days (21–59) | unresolved |
| Other vascular skin lesions (%) | ||||
| Splinter hemorrhage | – | – | 17 | – |
| Livedo racemosa | – | – | – | 33 |
| Ischemic events (%) | ||||
| Cardiac | – | – | 17 | 44 |
| Brain | – | – | 67 | 22 |
| Retina | – | 20 | – | – |
| Spleen | – | – | – | 11 |
| Gut | – | – | – | 22 |
| Nerve | – | – | – | 22 |
| Acute kidney injury (%) | – | – | 0 | 100 |
| Liver failure (%) | – | – | 0 | 33 |
| VTE (%) | – | – | 0 | 22 |
| Atrial fibrillation (%) | – | – | 33 | 22 |
| Syncope (%) | – | – | 50 | 44 |
| Bacterial superinfection (%) | – | – | 0 | 44 |
| SOFA | 0 | 0 | ≤ 2 | >2 |
| Exitus (%) | – | – | 17 | 67 |
| Discharged (%) | – | – | 67 | 11 |
| Readmission (%) | – | – | 0 | 0 |
| Follow-up, days (mean-range) |
38 (21–63) |
19 (11–24) |
44 (15–59) |
54 (2–90) |